[在患有肝细胞癌和阻塞性黄的患者中使用伦瓦提尼布治疗-A病例报告]
Tomomasa Tochio1, Yuto Kimura, Nahoko Fujita
1Dept. of Gastroenterology, Tenri Hospital.
Gan to kagaku ryoho. Cancer & chemotherapy
|December 24, 2025
概括
伦瓦提尼布有效地治疗了患有不可切除的肝细胞癌 (HCC) 和肝转移的患者的阻塞性黄. 这种方法在需要紧急治疗并保持肝功能时被证明是有用的.
科学领域:
- 肝胆道医学 肝胆道医学
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 晚期疾病的不可切除的肝细胞癌 (HCC) 存在重大治疗挑战.
- 阻塞性黄是一种严重的并发症,可以阻碍癌症治疗的开始.
- 紧急干预通常是需要管理黄和防止进一步的HCC进展.
研究的目的:
- 评估伦瓦提尼布在治疗二次阻塞性黄和不可切除的HCC的疗效.
- 评估在没有先前胆管排水的情况下治疗lenvatinib的安全性和效用,在肝功能保留的患者中.
主要方法:
- 一名患有不可切除的HCC,瘤血栓和肺转移的患者患有阻塞性黄.
- 由于该患者的儿童普格A分数 (6分) 和需要紧急干预,伦瓦替尼布作为治疗方法被使用.
- 通过对黄的临床评估和成像研究 (计算机断层扫描) 监测治疗反应.
主要成果:
- 阻塞性黄在伦瓦提尼布治疗10天内消失.
- 计算机断层扫描显示,治疗开始后14天,HCC的缩小和肝脏内胆道扩张的改善.
- 黄在延续林瓦替尼治疗期间没有复发.
结论:
- 伦瓦提尼布可以成为一种有价值的治疗选择,用于无法切除的HCC患者的阻塞性黄.
- 在需要紧急管理的情况下,未经先前胆管排水的情况下使用伦瓦提尼布治疗可能是可行的和有效的.
- 这一案例突出了管理复杂的黄HCC病例的潜在策略,改善了患者的治疗结果.
相关概念视频
01:26Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
165
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
165